Cubist Systematic Strategies, LLC Abb Vie Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $3.49 Million - $4.25 Million	-21,300 Reduced 24.37%	66,100 $13.1 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $1.81 Million - $2.11 Million	-11,700 Reduced 11.81%	87,400 $15 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $4.17 Million - $4.75 Million	-26,100 Reduced 20.85%	99,100 $18 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $963,200 - $1.08 Million	-7,000 Reduced 5.3%	125,200 $19.4 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $3.55 Million - $4.11 Million	-26,600 Reduced 16.75%	132,200 $19.7 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $2.12 Million - $2.64 Million	-16,000 Reduced 9.15%	158,800 $21.4 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $9.98 Million - $11.5 Million	-69,000 Reduced 28.3%	174,800 $27.9 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $13 Million - $15.6 Million	-94,300 Reduced 27.89%	243,800 $39.4 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $12.8 Million - $14.6 Million	95,100 Added 39.14%	338,100 $45.4 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $32.8 Million - $41.6 Million	238,000 Added 4760.0%	243,000 $37.2 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $659,900 - $818,750	5,000 New	5,000 $811,000

3,869

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.